ShockWave Therapy — full guide to the technology, how it works, uses, risks and practical details

Shockwave therapy (often abbreviated ESWT for extracorporeal shock wave therapy) is a non-invasive medical treatment that uses focused or radial acoustic (pressure) waves to stimulate biological repair processes, reduce pain and break down calcified deposits. It evolved from lithotripsy (breaking kidney stones) and today is used widely in orthopedics, sports medicine, urology, and some sexual-health indications. Below I explain the technology, the biological effects, major clinical uses, how a treatment is performed, evidence and outcomes, safety and contraindications, and where the field is headed.

1. Brief history and development

Shockwaves were first applied clinically in the 1980s to fragment kidney stones (extracorporeal shock wave lithotripsy, ESWL). Clinicians observed that the same type of acoustic energy could produce tissue effects beyond stone fragmentation — for example, stimulating healing in chronic tendon problems and breaking up calcific deposits — which led to the medical expansion of shockwave use into orthopedics, physical medicine and later into urology and sexual medicine. Modern devices were adapted to deliver different energy profiles (focused vs radial) and at lower intensities suitable for soft-tissue healing rather than stone destruction.
endourology.org
+1

1. What is a “shockwave” and the two main device types

A shockwave is a brief, high-pressure acoustic pulse that travels through tissue. Clinically relevant shockwave systems differ mainly by:

Focused shockwave therapy (fESWT / focused ESWT): Generates a true high-pressure acoustic pulse that converges at a defined focal point inside tissue. It penetrates deeper and concentrates energy at a specific depth — useful for deep lesions or calcific deposits.

Radial pressure wave therapy (rESWT or radial shockwave): Creates a pressure wave that disperses from the applicator tip into the tissue and is more superficial, with the highest energy at or near the skin surface and lower tissue penetration overall. Some vendors call this “radial pressure waves.”

Devices also vary by energy level (measured as energy flux density, mJ/mm²), pulse frequency and waveform shape — all of which influence how the body responds. Clinicians choose modality based on target depth, tissue type and desired biological effect.
PMC
+1

1. How shockwave therapy works — the biological mechanisms

Shockwaves provoke mechanical and biological responses on several levels:

Mechanical stimulation / microtrauma: The acoustic pulses produce rapid mechanical stress on cells and extracellular matrix. That micro-injury is controlled and triggers a repair cascade rather than destructive damage when delivered at therapeutic (low) intensities.

Neovascularization (new blood vessel formation): Shockwaves upregulate factors such as endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF), promoting new capillaries and improved local blood flow — crucial in chronically under-perfused tendons.

Cellular response and remodeling: Increased expression of growth factors, modulation of inflammatory cytokines, stimulation of stem/progenitor cell recruitment and changes in matrix-remodeling enzymes (MMPs) lead to tissue regeneration and reorganized collagen formation.

Analgesic effects: Shockwaves can decrease nociceptor sensitization, possibly via modulation of pain neurotransmitters and by interrupting unhelpful pain cycles. Immediate analgesic effects are sometimes reported, followed by longer-term structural improvements.

Fragmentation of calcifications: In calcific tendinopathy, focused waves can mechanically break down calcium deposits, aiding resorption and symptom relief.

1. Common clinical indications (where it’s used)

Shockwave therapy has many indications; the level of evidence varies by condition:

Plantar fasciitis (heel pain): One of the best-supported non-surgical uses. Many patients with chronic plantar fasciitis experience pain relief and improved function after ESWT.
PMC
+1

Achilles tendinopathy and patellar tendinopathy (jumper’s knee): Widely used in chronic tendinopathies with encouraging outcomes.
PMC

Calcific tendinitis of the shoulder: Focused ESWT can help fragment and resolve calcific deposits.
Lippincott Journals

Lateral epicondylitis (tennis elbow): Several trials show benefit for chronic cases.
PMC

Muscle injuries and delayed recovery in athletes: Used as adjunct therapy to accelerate return to play in selected cases.
BioMed Central

Sexual medicine (low-intensity shockwave therapy, Li-ESWT): Low-intensity focused shockwave therapy is being used to treat vasculogenic erectile dysfunction and Peyronie’s disease; many studies show improvements in erectile function, though protocols and devices differ and evidence is still evolving.
OUP Academic
+1

Other investigational or less-established uses include chronic wounds, bone healing stimulation and certain neuropathic pains — but these are areas of active research rather than settled practice.

1. Evidence and effectiveness — what the literature says

Overall, meta-analyses and clinical trials show meaningful benefits for several musculoskeletal conditions, especially chronic plantar fasciitis, rotator cuff calcific tendinopathy and certain chronic tendinopathies. Results depend heavily on parameters (energy, number of pulses and sessions), device type, and patient selection. For erectile dysfunction and urology, low-intensity shockwave therapy shows promise and several trials report improved erectile scores, but consensus about standardized protocols and long-term durability is still forming. Insurance and guideline acceptance varies by country and by clinical condition; some payers consider ESWT experimental for certain indications.
PMC
+1

1. Typical treatment protocol — what patients can expect

Assessment and selection: A clinician confirms the diagnosis (clinical exam ± imaging) and rules out contraindications.

Session length and number: A typical session lasts 10–20 minutes. Most protocols use 3–6 sessions spaced 1 week apart, sometimes with booster sessions. Energy levels and number of pulses (often thousands per session) are tailored to the condition.

Procedure: The applicator is placed on the skin over the target area using gel. Patients may feel sharp pulses; local anesthetic is generally avoided for musculoskeletal indications because reducing pain can blunt the therapeutic stimulus; however, some centers use local anesthesia for very painful treatments or deep focused waves.

Recovery: Most patients resume normal activities quickly. Temporary soreness, swelling or bruising is common for a few days. Full therapeutic benefit often appears over weeks to months as tissue remodeling occurs.
wwl.nhs.uk
+1

1. Side effects and contraindications

Common, minor side effects: transient pain during or after treatment, local redness, swelling, bruising, numbness or altered sensation. These usually resolve within days to weeks. Rare but serious risks (uncommon when correctly applied) include skin breakdown, infection (rare), tissue or nerve injury if inappropriate energy/dosing is used. Precise dosing and skilled application minimize risks. Typical contraindications include pregnancy, active infection at the treatment site, coagulation disorders or ongoing anticoagulation (relative), and certain implanted devices in the treatment field; shockwave should be avoided directly over growth plates in children. Clinicians always review medications and comorbidities before proceeding.
wwl.nhs.uk
+1

1. Practical considerations for patients and clinicians

Choose the right device and protocol: Focused for deep/calcific lesions; radial for more superficial problems. Energy and pulse counts matter — “one-size-fits-all” devices or low-dose protocols may underperform.
ScienceDirect
+1

Expect gradual improvement: Tissue remodeling is not immediate; many patients feel relief within weeks but maximal benefit may take months.

Combination therapies: ESWT is often combined with physiotherapy, eccentric loading exercises (for tendinopathies), or activity modification for best outcomes.

Insurance and cost: Coverage varies widely. In some health systems the therapy is routine; in others it’s considered adjunctive and may be out-of-pocket. Always check local policies.
anthem.com

1. Future directions and research gaps

Research continues on optimal dosing, head-to-head comparisons of focused versus radial devices, standardized protocols for sexual-health indications, and new applications (bone healing, chronic wounds, neuropathic pain). There is particular need for high-quality randomized trials with standardized parameters so clinicians can compare devices and protocols reliably. Recent studies continue to refine indications and show promising expanded uses, but standardization is the major remaining hurdle.
MedRxiv
+1

1. Bottom line — who may benefit?

Patients with chronic plantar fasciitis, calcific shoulder tendinitis, chronic Achilles or patellar tendinopathy, and some cases of tennis elbow are among those most likely to benefit from ESWT based on current evidence.

Low-intensity focused shockwave is a promising, non-invasive option for vasculogenic erectile dysfunction, but patients should discuss realistic expectations, protocol variability, and long-term data with specialists.

ESWT is generally safe when delivered by trained providers using appropriate energy settings, but it is not risk-free and is not a universal cure; patient selection, device choice, and integration with rehabilitation are key to success.